7 STRAITS VIEW, SINGAPORE, U0
Market cap: $2.3B (2/11/2026)
Price: $12.80
Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency
Investor Presentation
Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Positive Data from Wave Life Sciences' Phase 1 Trial of WVE-007 for Obesity
Corporate Presentation November 17, 2025
Reports Third Quarter 2025 Financial Results and Provides Business Update
Amended material disclosure
Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
Q3
Q2
Q1
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement